---
figid: PMC4085879__fonc-04-00170-g002
figlink: /pmc/articles/PMC4085879/figure/F2/
number: Figure 2
caption: 'Potential targets in T-ALL: PI3K/AKT/mTOR, cyclin D3:CDK4/6, BRD4/MYC. (A)
  BET bromodomain inhibitors displace BET bromodomain, such as BRD4, from chromatin
  by competitively binding to the acetyl lysine recognition pocket and lead to the
  repression of BRD4 transcriptional targets. (B) CDK4/6 inhibitors specifically inhibit
  CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation in early
  G1. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S-phase transition,
  thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis, and
  inhibiting cancer cell growth. (C) PI3K catalyzes phosphorylation of the D3 position
  on phosphoinositide to generate the second messenger phosphatidylinositol-3,4-5
  trisphosphate (PIP3) from phosphatidylinositol-3,4 bisphosphate (PIP2). PIP3 binds
  to the pleckstrin homology (PH) domains of the 3′ phosphoinositide-dependant kinase
  (PDK-1) and AKT causing both proteins to translocate to the cell membrane where
  they are subsequently activated. AKT activation stimulates metabolism, cell-cycle
  progression, survival and migration through phosphorylation of many physiological
  substrates, including mTOR. The tumor suppressor PTEN inhibits PI3K signaling by
  the dephosphorylation of PIP3. AKT can activate mTOR directly by phosphorylation
  at S2448 or indirectly by inhibition of the tuberous sclerosis complex TSC2. Potential
  inhibitors of the above described pathway are indicated in red.'
pmcid: PMC4085879
papertitle: New Approaches to Target T-ALL.
reftext: Giovanni Roti, et al. Front Oncol. 2014;4:170.
pmc_ranked_result_index: '22944'
pathway_score: 0.943282
filename: fonc-04-00170-g002.jpg
figtitle: 'Targets in T-ALL: PI3K/AKT/mTOR, cyclin D3:CDK4/6, BRD4/MYC'
year: '2014'
organisms: Homo sapiens
ndex: ae4ce932-deee-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4085879__fonc-04-00170-g002.html
  '@type': Dataset
  description: 'Potential targets in T-ALL: PI3K/AKT/mTOR, cyclin D3:CDK4/6, BRD4/MYC.
    (A) BET bromodomain inhibitors displace BET bromodomain, such as BRD4, from chromatin
    by competitively binding to the acetyl lysine recognition pocket and lead to the
    repression of BRD4 transcriptional targets. (B) CDK4/6 inhibitors specifically
    inhibit CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation
    in early G1. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S-phase
    transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA
    synthesis, and inhibiting cancer cell growth. (C) PI3K catalyzes phosphorylation
    of the D3 position on phosphoinositide to generate the second messenger phosphatidylinositol-3,4-5
    trisphosphate (PIP3) from phosphatidylinositol-3,4 bisphosphate (PIP2). PIP3 binds
    to the pleckstrin homology (PH) domains of the 3′ phosphoinositide-dependant kinase
    (PDK-1) and AKT causing both proteins to translocate to the cell membrane where
    they are subsequently activated. AKT activation stimulates metabolism, cell-cycle
    progression, survival and migration through phosphorylation of many physiological
    substrates, including mTOR. The tumor suppressor PTEN inhibits PI3K signaling
    by the dephosphorylation of PIP3. AKT can activate mTOR directly by phosphorylation
    at S2448 or indirectly by inhibition of the tuberous sclerosis complex TSC2. Potential
    inhibitors of the above described pathway are indicated in red.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDK1
  - SART3
  - DNER
  - AKT3
  - PIK3CA
  - MTOR
  - AKT2
  - E2F2
  - E2F3
  - BRD4
  - E2F1
  - MAPK1
  - MAPK3
  - PIK3CB
  - PIK3CD
  - MAPK12
  - AKT1
  - CRTC2
  - E2F7
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - MAPK8
  - MAPK11
  - PIK3CG
  - CDK4
  - CRTC1
  - MAPK14
  - PTEN
  - CCND2
  - CDK6
  - GNAL
  - E2F4
  - MAPK13
  - E2F5
  - E2F6
  - GNAS
  - CCND1
  - E2F8
  - PIK3R3
  - MAPK10
  - CCND3
  - MAPK9
  - Cancer
genes:
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: P110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: BET
  symbol: bet
  source: hgnc_alias_symbol
  hgnc_symbol: DNER
  entrez: '92737'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: BRD4
  symbol: BRD4
  source: hgnc_symbol
  hgnc_symbol: BRD4
  entrez: '23476'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TORC1/TORC2
  symbol: TORC2
  source: hgnc_alias_symbol
  hgnc_symbol: CRTC2
  entrez: '200186'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: TORC1/TORC2
  symbol: TORC1
  source: hgnc_alias_symbol
  hgnc_symbol: CRTC1
  entrez: '23373'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: G1/S
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: G1/S
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
